AVP, Global Immunology Marketing, IBD

Job Description

The Associate Vice President (AVP), Global Commercial Leader Inflammatory Bowel Disease (IBD), Immunology will lead the global strategy and enterprise launch readiness of our companys next immunology drug for Ulcerative Colitis (UC) and Crohn’s Disease (CD) indications .

The global brand leader is responsible for setting a bold aspirational commercial vision and guiding a cross-functional team to realize this vision. This is a business-critical role for our company. Our ability to make a meaningful impact on immunology diseases will be influenced by the leadership and vision of this role.

The Global Commercial Leader for IBD will provide commercial input into late-stage Business Development efforts, play an important role in supporting the commercial leadership of our IBD launches, exemplify our inclusive ways of working, embed advanced analytics into launch planning and contribute to the development of evolving commercial models in order to build value for patients, payers and Healthcare Providers (HCPs).

Primary Responsibilities

• Lead the Global Marketing Commercial teams for UC and CD and ensure integration of marketing, policy, Global Market Access (GMAx), Medical, Clinical and the Center for Observational and Real-world Evidence (CORE) in the development of an integrated global brand strategy for Tulisokibart IBD emerging portfolio.
• Collaborate with key markets stakeholders to ensure a unified flawless execution of the global brand strategy, value evidence plan, rapid and broad access, launch readiness go to market model while leveraging synergies across UC CD.
• Partner with Research and Development (RD) to optimize Product Development Team (PDT), development and launch readiness plans.
• Support development efforts with RD and Corporate Business development in IBD.
• Collaborate with Business Development Team to identify inorganic growth opportunities in the IBD market.
• Work closely with Early D